Zhejiang Wecome Pharmaceutical Company Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 195.74 million compared to CNY 183.78 million a year ago. Revenue was CNY 195.74 million compared to CNY 183.78 million a year ago.

Net income was CNY 27.53 million compared to CNY 22.92 million a year ago. Basic earnings per share from continuing operations was CNY 0.1901 compared to CNY 0.1583 a year ago. Diluted earnings per share from continuing operations was CNY 0.1901 compared to CNY 0.1583 a year ago.